跳至主要内容
临床试验/NCT01970930
NCT01970930已完成不适用

Treatment Strategies for Myeloproliferative Neoplasms by Targeting the Tumor Suppressor P53

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 131 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
131
试验地点
1
主要终点
Stem cell function

研究概览

简要总结

The purpose of the study is to isolate and characterize stem cells of patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) to find out why these cells are not working the way they should be and why they seem to be sensitive to regulatory factors in the blood, such as clotting.

详细描述

Specific Aim 1: Assess the effects of RG7112 on MPN HSC/HPC p53 levels and study how it affects MPN stem cell function.

Specific Aim 2. Assess the effects of a combination of low doses of IFNα and RG7112 on MPN HSC/HPC.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • polycythemia vera or essential thrombocythemia
  • agree to give blood for study

排除标准

  • 未提供

结局指标

主要结局

Stem cell function

时间窗: at one time study visit

Assess the effects of RG7112 on MPN HSC/HPC p53 levels and study how it affects MPN stem cell function.

次要结局

  • CD34+ cells assays(at one time study visit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验